Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	78112
Country	China

Received	2022-06-08 06:01
Peer-Review Started	2022-06-08 06:04
To Make the First Decision
Return for Revision	2022-06-23 15:44
Revised	2022-07-06 17:53
Second Decision	2022-08-18 03:10
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-08-22 17:48
Articles in Press	2022-08-22 17:48
Publication Fee Transferred
Edit the Manuscript by Language Editor	2022-09-06 08:44
Typeset the Manuscript	2022-10-08 04:01
Publish the Manuscript Online	2022-10-14 12:54

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer having neoadjuvant chemoradiotherapy
Manuscript Source	Unsolicited Manuscript
All Author List	Jie-Yi Zhao, Qing-Qing Tang, Yu-Ting Luo, Shu-Min Wang, Xiao-Rui Zhu and Xiao-Yu Wang
ORCID	Author(s) ORCID Number Jie-Yi Zhao http://orcid.org/0000-0001-8993-0121 Qing-Qing Tang http://orcid.org/0000-0001-8993-0121 Yu-Ting Luo http://orcid.org/0000-0002-2783-1643 Shu-Min Wang http://orcid.org/0000-0001-8103-316X Xiao-Rui Zhu http://orcid.org/0000-0003-3611-0263 Xiao-Yu Wang http://orcid.org/0000-0003-0936-2094
Funding Agency and Grant Number
Corresponding Author	Xiao-Yu Wang, MD, Doctor, Department of Neurosurgery, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu 610041, Sichuan Province, China. yuxixi1052006@126.com
Key Words	Rectal cancer; Neoadjuvant chemoradiotherapy; Scoring system; Carcinoembryonic antigen; Carbohydrate antigen 19-9; Predictive
Core Tip	The combination of post-neoadjuvant chemoradiotherapy (NCRT) carcinoembryonic antigen and carbohydrate antigen 19-9 could be a prognosis predictor for clinical stage II/III rectal cancer patients receiving NCRT, the combined index had a stronger predictive effects than index alone.
Publish Date	2022-10-14 12:54
Citation	Zhao JY, Tang QQ, Luo YT, Wang SM, Zhu XR, Wang XY. Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer having neoadjuvant chemoradiotherapy. World J Gastrointest Oncol 2022; 14(10): 2014-2024
URL	https://www.wjgnet.com/1948-5204/full/v14/i10/2014.htm
DOI	https://dx.doi.org/10.4251/wjgo.v14.i10.2014

Full Article (PDF)	WJGO-14-2014.pdf
Full Article (Word)	WJGO-14-2014.docx
Manuscript File	78112_Edited-Ma JY-MedE.docx
Answering Reviewers	78112-Answering reviewers.pdf
Audio Core Tip	78112-Audio core tip.mp3
Biostatistics Review Certificate	78112-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	78112-Conflict-of-interest statement.pdf
Copyright License Agreement	78112-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	78112-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	78112-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	78112-Language certificate.pdf
Peer-review Report	78112-Peer-review(s).pdf
Scientific Editor Work List	78112-Scientific editor work list.pdf